Clinical Outcomes and Patient Satisfaction With Use of the Amma System

Running, not enrolling

Conditions studied: Breast Cancer

In brief

The primary goal is to conduct a pilot evaluation of the Amma device, to determine whether it is feasible to offer as an option for patients within oncology suites within the PH\&S system.

Key facts

Study ID

NCT05508984

Run by

Providence Health & Services

People needed

15

Starts

2022-08-22

Expected to finish

2026-12-01

Last updated by the study team

2026-04-24

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women with stage I-III breast cancer are eligible to participate if:
• They consent to conduct baseline (week 0) and follow-up (week 4 post-chemo) surveys/interviews
• They consent to be photographed at baseline (week 0) and follow-up (week 4 post-chemo), to document hair retention outcomes
• Curative-intent chemotherapy is planned with a taxane-based, anthracycline-sparing chemotherapy regimen (which includes but may not be limited to: TC x 4, T x 12, TCHP x6)

Where it is running

• Providence Cancer Institute - Newberg Clinic — Newberg, Oregon, United States
• Providence Portland Medical Center — Portland, Oregon, United States
• Providence Oncology and Hematology Care - Westside — Portland, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.